Cargando…

Protein kinase D1 regulates metabolic switch in pancreatic cancer via modulation of mTORC1

BACKGROUND: Protein kinase D1 (PKD1) is a serine–threonine kinase that regulates various functions within the cell. Herein, we report the significance of PKD1 expression in glucose metabolism resulting in pancreatic cancer (PanCa) progression and chemo-resistance. METHODS: PKD1 expression in PanCa w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumari, Sonam, Khan, Sheema, Sekhri, Radhika, Mandil, Hassan, Behrman, Stephen, Yallapu, Murali M., Chauhan, Subhash C., Jaggi, Meena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964700/ https://www.ncbi.nlm.nih.gov/pubmed/31819177 http://dx.doi.org/10.1038/s41416-019-0629-9

Ejemplares similares

MUC13 drives cancer aggressiveness and metastasis through the YAP1-dependent pathway
por: Doxtater, Kyle, et al.
Publicado: (2023)

MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer
por: Kumari, Sonam, et al.
Publicado: (2018)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
por: Samanta, Kamalika, et al.
Publicado: (2019)

Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer)
por: Sikander, Mohammed, et al.
Publicado: (2019)

Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore
por: Chaib, Mehdi, et al.
Publicado: (2022)

Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells
por: Kumari, Sonam, et al.
Publicado: (2021)

Synthesis and Antitumor Activity of Brominated-Ormeloxifene (Br-ORM) against Cervical Cancer
por: Sikander, Mohammed, et al.
Publicado: (2023)

MUC13 Interaction with Receptor Tyrosine Kinase HER2 Drives Pancreatic Ductal Adenocarcinoma Progression
por: Khan, Sheema, et al.
Publicado: (2016)

Curcumin Nanoformulation for Cervical Cancer Treatment
por: Zaman, Mohd S., et al.
Publicado: (2016)

Integrative big transcriptomics data analysis implicates crucial role of MUC13 in pancreatic cancer
por: Dhasmana, Anupam, et al.
Publicado: (2023)

Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
por: Sikander, Mohammed, et al.
Publicado: (2019)

Ormeloxifene nanotherapy for cervical cancer treatment
por: Chauhan, Neeraj, et al.
Publicado: (2019)

Scope of nanotechnology in ovarian cancer therapeutics
por: Yallapu, Murali M, et al.
Publicado: (2010)

Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
por: Dan, Nirnoy, et al.
Publicado: (2018)

MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer
por: Khan, Sheema, et al.
Publicado: (2014)

Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer
por: Chowdhury, Pallabita, et al.
Publicado: (2018)

Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1
por: Ganju, Aditya, et al.
Publicado: (2018)

Revisiting stroma in pancreatic cancer
por: Khan, Sheema, et al.
Publicado: (2015)

Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells
por: Chauhan, Neeraj, et al.
Publicado: (2020)

miR-205: A Potential Biomedicine for Cancer Therapy
por: Chauhan, Neeraj, et al.
Publicado: (2020)

Biomolecule-functionalized nanoformulations for prostate cancer theranostics
por: Pranav, et al.
Publicado: (2022)

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes
por: Yallapu, Murali Mohan, et al.
Publicado: (2011)

Protein Kinase D1 attenuates tumorigenesis in colon cancer by modulating β-catenin/T cell factor activity
por: Sundram, Vasudha, et al.
Publicado: (2014)

miRNA-205: a future therapeutic molecule for liver diseases
por: Cabrera, Marco, et al.
Publicado: (2023)

mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)

Withania somnifera as a potential future drug molecule for COVID-19
por: Kashyap, Vivek K, et al.
Publicado: (2020)

Milk exosomes: Nature's abundant nanoplatform for theranostic applications
por: Adriano, Benilde, et al.
Publicado: (2021)

Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018)

Bioactive nanotherapeutic trends to combat triple negative breast cancer
por: Chowdhury, Pallabita, et al.
Publicado: (2021)

Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy
por: Laskar, Partha, et al.
Publicado: (2023)

Tannic Acid Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in Prostate Cancer
por: Nagesh, Prashanth K.B., et al.
Publicado: (2018)

Regulation of Autophagy through TORC1 and mTORC1
por: Noda, Takeshi
Publicado: (2017)

Combination of mTOR and EGFR Kinase Inhibitors Blocks mTORC1 and mTORC2 Kinase Activity and Suppresses the Progression of Colorectal Carcinoma
por: Wang, Quan, et al.
Publicado: (2013)

Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
por: Chen, Long, et al.
Publicado: (2015)

The metabolic waste ammonium regulates mTORC2 and mTORC1 signaling
por: Merhi, Ahmad, et al.
Publicado: (2017)

An mTORC1-to-CDK1 Switch Maintains Autophagy Suppression during Mitosis
por: Odle, Richard I., et al.
Publicado: (2020)

mTORC1 Regulates the Metabolic Switch of Postnatal Cardiomyocytes During Regeneration
por: Paltzer, Wyatt G., et al.
Publicado: (2023)

Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
por: Luo, Yan, et al.
Publicado: (2015)

Bay Leaf Extract-Based Near-Infrared Fluorescent Probe for Tissue and Cellular Imaging
por: Adriano, Benilde, et al.
Publicado: (2021)

Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer
por: Kashyap, Vivek K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_leckvcc4lbg2ml5tu2itsq2676